Health Outcomes in Rheumatoid Arthritis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00346411

Acronym

HORA

Enrollment

164

Registered

2006-06-29

Start date

2005-09-01

Completion date

2011-12-12

Last updated

2017-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Keywords

rheumatoid arthritis, mood, adherence, medication

Brief summary

This research is being done to help us learn about how different factors related to treatment affect rheumatoid arthritis (RA). This is not a treatment study. We will follow the patient for one year as he or she receives usual treatment from his or her rheumatologist. Up to 360 adults with RA may join this study.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

19 Years to No maximum

Healthy volunteers

Inclusion criteria

* Males and females age 19 or older * Current active, adult-onset rheumatoid arthritis who meet American College of Rheumatology (ACR) criteria for RA and have: (ACR functional class I-III), defined as: * 3 or more swollen or tender joints and * Morning stiffness of 45min or longer * OR judged by their rheumatologist to have active disease * No evidence of other inflammatory diseases (e.g., Crohn's, IBS) * Functional class I, II or III

Exclusion criteria

* Individuals with significant cardiovascular disease (CHF, stroke, MI) * Unwilling to have medications monitored and/or comply with protocol * Not fluent in English * Planning to move from area within next year or change health insurance (which would preclude ongoing care by a Johns Hopkins rheumatologist) * Enrolled in study evaluating efficacy of new or existing RA medications

Countries

United States

Outcome results